- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04231578
Couple HOPES (Helping Overcome PTSD and Enhance Satisfaction) (HOPES)
April 10, 2024 updated by: Candice Monson, Toronto Metropolitan University
Couple HOPES: Initial Development of a Guided, Internet-delivered Couple Intervention for Posttraumatic Stress Disorder (PTSD) and Relationship Enhancement
Posttraumatic stress disorder (PTSD) is a common and disabling condition associated with intimate relationship problems and mental health problems in partners of those with PTSD.
Recognizing the need to improve access to evidence-based interventions for those with PTSD and their families, our team has developed an Internet-delivered, self-help intervention to improve PTSD, enhance relationships, and improve partners' mental health: Couple HOPES (Helping Overcome PTSD and Enhance Satisfaction).
Couple HOPES presents text and video-based content across seven self-help intervention modules, with modest support from paraprofessional coaches.
Although the Couple HOPES platform has been developed, it remains uncertain whether Couple HOPES is feasible, usable, and efficacious in reducing PTSD and enhancing intimate relationship functioning.
The proposed project aims to refine and finalize Couple HOPES with couples that include a veteran, service member or first responder with significant PTSD symptoms.
This project includes initial testing of the intervention's preliminary efficacy, safety, and feasibility in a series of 10 couples (Phase 1), then in an uncontrolled trial of 20 couples (Phase 2), and then a randomized clinical trial comparing its efficacy to a delayed intervention control condition in 70 couples.
Potential benefits of this study include couples learning new skills to reduce PTSD symptoms and enhance relationship functioning, although this is not guaranteed.
Risks include participants finding the assessments distressing, or possible worsening of PTSD symptoms or relationship functioning.
These risks will be mitigated by continuous monitoring of PTSD symptoms, relationship functioning, and adverse events, and intervention by study staff.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
152
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Kristen M Whitifeld, B.A.
- Phone Number: 1+2369 416-979-5000
- Email: impact.lab@ryerson.ca
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5B 1Y3
- Candice M. Monson
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Individual who is a Canadian military member, veteran, or first responder with clinically significant levels of PTSD symptoms
- Must be willing to be audio-recorded for coaching sessions
- Intimate partner willing to participant and complete intervention modules together
- Access to high speed internet
Exclusion Criteria:
- Elevated suicide risk
- Severe physical aggression between partners in the past year
- Clinically significant PTSD symptoms in both members of the dyad
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Immediate Couple HOPES
Immediately assigned to receive seven modules of an Internet-delivered self-help intervention with paraprofessional coaching for PTSD completed at the participant's own pace within 8 weeks.
|
Couple HOPES is a guided self-help intervention for individuals with PTSD and their partners based on Cognitive-Behavioral Conjoint Therapy for PTSD (Monson & Fredman, 2012).
This intervention consists of text and video-based content across seven intervention modules and phone and online-based coaching sessions with a paraprofessional.
Participants are able to complete these modules in their own home or private location of their choosing.
The primary outcomes are PTSD symptoms, relationship satisfaction, and the mental health and wellbeing of partners of those with PTSD.
|
No Intervention: Delayed Intervention
Participants will not receive Couple HOPES for the first 8 weeks, and complete assessments at the beginning, middle, and end of this period.
After this 8-week delay, participants will then receive seven modules of an Internet-delivered self-help intervention with paraprofessional coaching for PTSD completed at the participant's own pace within 8 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders-5 (PCL-5) with change measured as mean change from baseline
Time Frame: Baseline, week 3, week 8, approximately once a week during treatment (for up to 8 weeks), after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
Scores on the PCL-5 range from 0 to 80, with 80 being the most severe PTSD symptoms.
|
Baseline, week 3, week 8, approximately once a week during treatment (for up to 8 weeks), after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
Couple Satisfaction Index (CSI-4) with change measured as mean change from baseline
Time Frame: Baseline, week 3, week 8, approximately once a week during treatment (for up to 8 weeks), after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
Score on the CSI-4 range from 0 to 21, with 21 being the most satisfied.
|
Baseline, week 3, week 8, approximately once a week during treatment (for up to 8 weeks), after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean change from baseline on Ineffective Arguing Inventory
Time Frame: Baseline, week 3, week 8, after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
Score range from 0 to 40, with 40 representing highly ineffective arguing.
|
Baseline, week 3, week 8, after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Significant Others' Responses to Trauma Scale with change measured as mean change from baseline
Time Frame: Baseline, week 3, week 8, after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
Scores range from 0 to 76, with 76 representing high partner accommodation.
|
Baseline, week 3, week 8, after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
Mean change from baseline on depression as measured by the Patient Health Questionnaire
Time Frame: Baseline, week 3, week 8, after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
Scores range from 0 to 27, with 27 being the most depressed.
|
Baseline, week 3, week 8, after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
Mean change from baseline on alcohol use as measured by the Alcohol Use Disorders Identification Test: Self-Report Version
Time Frame: Baseline, week 3, week 8, after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
Scores range from 0 to 40, with a higher score signifying an alcohol use disorder.
|
Baseline, week 3, week 8, after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
Mean change from baseline in drug use based on the Drug Abuse Screen Test
Time Frame: Baseline, week 3, week 8, after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
Scores range from 0 to 10, with 10 being a severe level of problems related to drug abuse.
|
Baseline, week 3, week 8, after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
Generalized Anxiety Disorder symptoms with change measured as mean change from baseline
Time Frame: Baseline, week 3, week 8, after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
Scores range from 0 to 21, with 21 representing the highest level of anxiety.
|
Baseline, week 3, week 8, after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
State-Trait Anger Expression Inventory with change measured as mean change from baseline
Time Frame: Baseline, week 3, week 8, after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
Scores range from 0 to 40, with 40 representing higher levels of anger.
|
Baseline, week 3, week 8, after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
Mean change from baseline in perceived health measured with one item "How satisfied are you with your health"
Time Frame: Baseline, week 3, week 8, after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
Scores range from 1 to 5, with 5 being the most satisfied.
|
Baseline, week 3, week 8, after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
Trauma-Related Guilt Inventory with change measured as mean change from baseline
Time Frame: Baseline, week 3, week 8, after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
Baseline, week 3, week 8, after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
|
Mean change from baseline in work functioning measured with one item "Please rate your ability to function at work. If you do not work outside the home, please rate your ability to complete household tasks."
Time Frame: Baseline, week 3, week 8, after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
Baseline, week 3, week 8, after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
|
Mean change from baseline in quality of life measured with one item "How would you rate your quality of life."
Time Frame: Baseline, week 3, week 8, after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
Baseline, week 3, week 8, after 3 modules are completed or 3 weeks into treatment, after 7 modules are completed or 8 weeks into treatment, 3 month post-treatment follow-up
|
|
Participant ratings of intervention satisfaction as indicated by the Client Satisfaction Questionnaire
Time Frame: After 7 modules are completed or 8 weeks into treatment
|
After 7 modules are completed or 8 weeks into treatment
|
|
Feasibility as measured by number of treatment sessions attended and rate of participant dropout
Time Frame: Once a week during treatment (for up to 8 weeks)
|
Once a week during treatment (for up to 8 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Candice M Monson, PhD, Toronto Metropolitan University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Monson, C. M., & Fredman, S. J. (2012). Cognitive-behavioral conjoint therapy for PTSD: Harnessing the healing power of relationships. New York, NY: Guilford.
- Monson CM, Wagner AC, Crenshaw AO, Whitfield KM, Newnham CM, Valela R, Varma S, Di Bartolomeo AA, Fulham L, Collins A, Donkin V, Mensah DH, Landy MSH, Samonas C, Morland L, Doss BD, Fitzpatrick S. An uncontrolled trial of couple HOPES: A guided online couple intervention for PTSD and relationship enhancement. J Fam Psychol. 2022 Sep;36(6):1036-1042. doi: 10.1037/fam0000976. Epub 2022 Mar 10.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 31, 2020
Primary Completion (Actual)
January 15, 2023
Study Completion (Actual)
January 15, 2023
Study Registration Dates
First Submitted
December 18, 2019
First Submitted That Met QC Criteria
January 13, 2020
First Posted (Actual)
January 18, 2020
Study Record Updates
Last Update Posted (Actual)
April 12, 2024
Last Update Submitted That Met QC Criteria
April 10, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CIHR-IRSC:0525007697 (Other Grant/Funding Number: Canadian Institutes of Health Research (CIHR) 2018-2019 Foundation Grant)
- W7714-207266 (Other Grant/Funding Number: National Defence Security Orders and Directives)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Posttraumatic Stress Disorder
-
University Hospital, ToursCompletedPostTraumatic Stress DisorderFrance
-
The University of Texas Health Science Center at...University of Pennsylvania; Brooke Army Medical Center; C.R.Darnall Army Medical... and other collaboratorsCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Icahn School of Medicine at Mount SinaiCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Berlin Center for the Treatment of Torture VictimsCompletedPosttraumatic Stress Disorder (PTSD)Germany
-
VA Office of Research and DevelopmentCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Michael E. DeBakey VA Medical CenterSouth Central VA Mental Illness Research, Education & Clinical CenterCompletedPosttraumatic Stress Disorder (PTSD)United States
-
TEMPVA Research Group, Inc.C.R.Darnall Army Medical Center; VA Boston Healthcare System; Central Texas Veterans...UnknownPosttraumatic Stress Disorder, Combat-relatedUnited States
-
VA Office of Research and DevelopmentCompletedPosttraumatic Stress Disorder (PTSD)United States
-
VA Office of Research and DevelopmentCompleted
-
Yale UniversityNational Center for PTSDCompletedPosttraumatic Stress Disorder (PTSD)United States
Clinical Trials on Couple HOPES Guided, Internet-Delivered, Self-Help Intervention
-
York UniversityActive, not recruitingPosttraumatic Stress DisorderCanada
-
Universidad Nacional Autonoma de MexicoNational Council of Science and Technology, MexicoNot yet recruitingDepression | Anxiety Disorders | Trauma and Stressor Related Disorders | Emotional DisorderMexico
-
Stockholm UniversityCompletedSocial Anxiety DisorderSweden
-
Kaiser PermanenteOregon Health and Science UniversityCompleted
-
University of BernUniversitätsklinikum Hamburg-EppendorfCompletedSchizophrenia | Hallucinations | Persecutory DelusionGermany, Switzerland
-
Johannes Gutenberg University MainzLinkoeping UniversityCompleted
-
Javier Garcia CampayoCarlos III Health InstituteCompleted
-
University Medical Center GroningenCompletedFunctional Motor DisorderNetherlands
-
Virginia Commonwealth UniversityCompletedDisordered Eating BehaviorsUnited States
-
University of California, San FranciscoTobacco Related Disease Research ProgramCompletedCigarette SmokingUnited States